WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia
Zwi Berneman(University of Antwerp), Viggo Van Tendeloo(Infectious Diseases Institute), Sébastien Anguille(Antwerp University Hospital), Haruo Sugiyama(The University of Osaka), Katrien Vermeulen(University of Antwerp), Alain Gadisseur(Antwerp University Hospital), Griet Nijs(University of Antwerp), Yusuke Oji(The University of Osaka), Inge Vrelust(University of Antwerp), Kristin Ladell(Cardiff University), Nathalie Cools(University of Antwerp), I. Jolanda de Vries(Radboud University Nijmegen), Wilfried Schroyens(Antwerp University Hospital), Emma Gostick(University Hospital of Wales), Evelien Smits(University of Antwerp), Ann an de Velde(University of Antwerp), David A. Price(University Hospital of Wales), Yoshitaka Oka(The University of Tokyo), Ann Van Driessche(University of Antwerp), Barbara Stein(University of Antwerp), Katrien Pieters(University of Antwerp)
Cited by 6
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|The Journal of Experimental Medicine|2004|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
HIV preferentially infects HIV-specific CD4+ T cells
|Nature|2002|1.3k